Centaurin-alpha(1) is a member of the family of ADP-ribosylation factors (ARF) GTPase activating proteins (GAPs), although ARF GAP activity has not yet been demonstrated. The human homologue, centaurin-alpha(1) functionally complements the ARF GAP activity of Gcs1 in yeast. Although Gcs1 is involved in the formation of actin filaments in vivo, the function of centaurin remains elusive. We have identified a number of novel centaurin-alpha(1) binding partners; including CKIalpha and nucleolin. In this report, we have focused on the interaction of centaurin-alpha(1) with PKC. All groups of PKC associate directly through their cysteine rich domains. Centaurin-alpha(1) is also a substrate for all PKC classes and we have identified the two sites of phosphorylation. This is the first report of a kinase that phosphorylates centaurin-alpha(1).

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0006-291x(03)01187-2DOI Listing

Publication Analysis

Top Keywords

arf gap
8
gap activity
8
centaurin-alpha1
7
centaurin-alpha1 associates
4
associates phosphorylated
4
phosphorylated isoforms
4
isoforms protein
4
protein kinase
4
kinase centaurin-alpha1
4
centaurin-alpha1 member
4

Similar Publications

Article Synopsis
  • Research indicates that despite existing therapies, the outlook for patients with refractory or recurrent rhabdomyosarcoma (RMS) remains poor, prompting exploration of differentiation-inducing treatments.
  • In preclinical models of RAS-mutant PAX fusion-negative RMS, MEK1/2 inhibition has shown potential to encourage differentiation, slow tumor growth, and extend survival, although responses are often temporary.
  • The study identifies ASAP1 and ARF1 as crucial regulators in promoting differentiation in FN-RMS cells, revealing that targeting these molecules may enhance treatment strategies by affecting key transcriptional regulators, such as WWTR1 (TAZ).
View Article and Find Full Text PDF

ASAP1 and its paralog ASAP2 belong to a PIP-dependent Arf GTPase-activating protein (Arf-GAP) family capable of modulating membrane and cytoskeletal dynamics. ASAPs regulate cell adhesive structures such as invadosomes and focal adhesions during cell attachment and migration. Malfunctioning of ASAP1 has been implicated in the malignant phenotypes of various cancers.

View Article and Find Full Text PDF

Laxative misuse is a well-known occurrence, most often identified in patients struggling with eating disorders. Polyethylene glycol (PEG) 3350 is a readily available, well-tolerated osmotic laxative. High doses of PEG 3350 may cause gastrointestinal upset, diarrhea, dehydration, and electrolyte imbalance, although systemic toxicity is infrequently reported.

View Article and Find Full Text PDF

Objectives: The association between diuretic use and cardiorenal outcomes remains limited in patients with stage 3-5 chronic kidney disease (CKD) and hypertension. To address this gap, we aim to investigate the long-term clinical impact of diuretic use with its pharmacological classification in Taiwanese patients with stage 3-5 CKD and hypertension who were concurrently received angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs).

Methods: Using data from the National Health Insurance Research Database (January 2008 to December 2019), we focused on individuals with stage 3-5 CKD receiving ACEIs/ARBs between 2010 and 2018.

View Article and Find Full Text PDF

Renal dysfunction, including acute renal failure (ARF) and chronic kidney disease (CKD), continues to present significant health challenges, with renal ischemia-reperfusion injury (IRI) being a pivotal factor in their development and progression. This condition, notably impacting kidney transplantation outcomes, underscores the urgent need for innovative therapeutic interventions. The role of opioid agonists in this context, however, remains a subject of considerable debate.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!